Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary

European Journal of Public Health

Volumn 19, Issue 3, 2009, Pages 260-265

  Anna Gyarmathy, V ^a   Neaigus, Alan ^b,c   Ujhelyi, Eszter ^d  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c Department of Medicine   (United States)

^d Szent Lszl Hospital   (Hungary)

Author keywords

Central Europe; Hepatitis infections; HIV AIDS; Injecting drug use; Marginalized populations

Indexed keywords

AMPHETAMINE;

ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG USE; GONORRHEA; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNGARY; MIXED INFECTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TUBERCULOSIS;

ADULT; ANALYSIS OF VARIANCE; DRUG USERS; EUROPE; FEMALE; HUMANS; HUNGARY; INFECTION; MALE; PREVALENCE; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 66249103301     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckp009     Document Type: Article

References (36)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2007: the state of the drugs problem in Europe. Lisbon: EMCDDA, 2007.
2. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007;370:2127-37.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
4. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007;44:1222-8.
5. Salomon N, Perlman DC, Friedmann P, et al. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis 2000;4:47-54.
6. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Ciln Gastroenterol 2001;33:20-6.
7. Lin L, Verslype C, van Pelt JF, et al. Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses. Eur J Gastroenterol Hepatol 2006;18:1311-9.
8. Spada E, Genovese D, Tosti ME, , et al. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J Hepatol 2005;43:958-64.
9. Leino T, Leinikki P, Hyypia T, et al. Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis 1997;29:213-6.
10. Estrada AL. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep 2002;117(Suppl 1):S126-34.
11. Tyndall MW, Wood E, Zhang R, et al. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment. Harm Reduct J 2006;3:36.
12. Estrada AL. Health disparities among African-American and Hispanic drug injectors - HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS 2005;19(Suppl 3):S47-52.
13. Raoult D, Foucault C, Brouqui P. Infections in the homeless. Lancet Infect Dis 2001;1:77-84.
14. Gyarmathy VA, Ujhelyi E, Neaigus A. HIV and selected blood-borne and sexually transmitted infections in a predominantly Roma (Gypsy) neighbourhood in Budapest, Hungary: a rapid assessment. Cent Eur J Public Health 2008;16:124-7.
15. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 2003;361:1035-44.
16. Friedman SR, Kippax SC. Phaswana-Mafuya N, et al. Emerging future issues in HIV/AIDS social research. AIDS 2006;20:959-65.
17. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe, end year report 2006. Saint Maurice: Institute de Veille Sanitaire, 2007.
18. National Center for Epidemiology. HIV/AIDS situation in Hungary [in Hungarian]. Epinfo 2007;7:86-7.
19. Rácz J, Gyarmathy VA, Neaigus A, et al. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007;19:59-66.
20. Ujhelyi E, Tarjan V, Szomor K, et al. Prevalence of Hl^V, HBsAg, and HCV infection among Hungarian drug users. Int Conf ALDS 1998; (abstract no. 60099).
21. Topolánszky Á. Jelentés a magyarországi kábítószerhelyzetrol. Budapest: GYISM, 2002.
22. Gyarmathy VA, Neaigus A. The effect of personal network exposure on injecting equipment sharing among Hungarian IDUs. Connections 2006;15:29-42.
23. Centers for Disease Control and Prevention. Interpretation of the Hepatitis B Panel, 2005. http://www.cdc.gov/hepatitis/HBV/PDFs/SerologicChart8. pdf (accessed 5 February 2009).
24. Fisher DG, Reynolds GL, Jaffe A, et al. Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. J Addict Dis 2006;25:25-32.
25. Gyarmathy VA, Neaigus A. Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection. J Urban Health 2005;82:iv101-12.
26. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994;38:67-78.
27. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004;132:1005-22.
28. Neaigus A, Gyarmathy VA, Miller M, et al. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend 2007;89:234-43.
29. Strathdee SA, Philbin MM, Semple SJ, et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend 2008;92:132-40.
30. Azim T, Chowdhury EI, Reza M, et al. Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a cohort study. Harm Reduct J 2006;3:33.
31. Rothenberg RB, Long DM, Sterk CE, et al. The Atlanta Urban Networks Study: a blueprint for endemic transmission. AIDS 2000;14:2191-200.
32. Rothenberg R. The relevance of social epidemiology in HIV/AIDS and drug abuse research. Am J Prev Med 2007;32:S147-53.
33. Koupilova I, Epstein H, Holcik J, et al. Health needs of the Roma population in the Czech and Slovak Republics. Soc Sci Med 2001;53:1191-204.
34. Kabakchieva E, Amirkhanian YA, Kelly JA, et al. High levels of sexual HIV/ STD risk behaviour among Roma (Gypsy) men in Bulgaria: patterns and predictors of risk in a representative community sample. Int J STD AIDS 2002;13:184-91.
35. Gyarmathy VA, Racz J, Neaigus A, et al. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary. AIDS Educ Prev 2004;16:276-87.
36. Iwarson S. New target groups for vaccination against hepatitis A: homosexual men, injecting drug users and patients with chronic hepatitis. Scand J Infect Dis 1998;30:316-8.